Skip to main content

Table 4 Linear multivariate analyses using (A) lipid index and (B) fibrous cap thickness as the dependent variable, (1) In all patients (n = 166), (2) in DM patients (n = 83), and (3) in non-DM patient (n = 83)

From: Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography

(1) in all patients

(A)

Variables

Non-standardized coefficients

Standardized coefficients β

t

P value

B

SE

MAGE

31.9

4.239

0.527

7.541

<0.001

Mean BG

10.4

5.075

0.143

2.051

0.042

(B)

MAGE

−0.868

0.171

−0.392

−5.076

<0.001

Time in hypoglycemia

−3.789

1.828

−0.160

−0.160

0.040

(2) in DM groups

(A)

MAGE

35.0

6.554

0.515

5.346

<0.001

(B)

MAGE

−0.906

0.212

−0.433

−4.265

<0.001

(3) in non-DM patients

(A)

MAGE

31.9

5.633

0.532

5.661

<0.001

(B)

MAGE

−1.357

0.280

−0.474

−4.847

<0.001

  1. BG: blood glucose; MAGE: mean amplitude of glycemic excursion